Related Experiment Videos
Lipid oxidation enhances the function of activated protein C
O Safa1, K Hensley, M D Smirnov
1Department of Cardiovascular Biology, Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, Oklahoma City 73104, USA.
The Journal of Biological Chemistry
|October 31, 2000
Summary
Oxidized membrane phospholipids enhance the anticoagulant function of activated protein C (APC), potentially limiting thrombus formation. However, anti-phospholipid antibodies can block this protective effect, contributing to thrombotic disease.
Area of Science:
- Biochemistry
- Hematology
- Cell Biology
Background:
- Lipid oxidation products are increasingly recognized for roles beyond tissue injury, including cell activation and anti-inflammatory signaling.
- The interplay between lipid oxidation and hemostasis, particularly anticoagulant pathways, requires further elucidation.
Purpose of the Study:
- To investigate the impact of membrane phospholipid oxidation on hemostatic balance.
- To determine how lipid oxidation affects the function of activated protein C (APC) and its interaction with protein S.
Main Methods:
- Studied the effect of natural phospholipid oxidation on membrane surface properties.
- Assessed the support of APC function and thrombin generation on oxidized membranes.
- Investigated the role of phosphatidylethanolamine, phosphatidylserine, and fatty acid polyunsaturation.
- Examined the impact of anti-phospholipid antibodies from thrombotic patients on APC function.
Main Results:
- Membrane phospholipid oxidation enhanced the surface's ability to support activated protein C (APC) anticoagulant function.
- Oxidation did not significantly alter the support of thrombin generation.
- Lipid oxidation potentiated protein S enhancement of APC-mediated factor Va inactivation.
- Specific anti-phospholipid antibodies blocked the oxidation-dependent enhancement of APC function.
Conclusions:
- Oxidized phospholipids can remodel membrane surfaces to increase anticoagulant function, potentially reducing thrombogenicity at thrombus or injury sites.
- The oxidation-dependent enhancement of APC function requires specific phospholipid components and fatty acid unsaturation.
- Anti-phospholipid antibodies that inhibit this protective mechanism may contribute to thrombus progression and thrombotic diseases.